Tarsus Pharmaceuticals, Inc.

27.94 USD
-0.06 (-0.21%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Tarsus Pharmaceuticals, Inc. stock is down -3.12% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 9 July’s closed higher than June. In the last 4 Unusual Options Trades, there were 4 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
04 Jun 18:09 18 Oct, 2024 35.00 CALL 70 0
21 Jun 14:47 16 Aug, 2024 30.00 CALL 230 0
05 Jul 19:29 18 Oct, 2024 35.00 CALL 200 122
05 Jul 19:29 16 Aug, 2024 30.00 CALL 200 235

About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the. treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction.